Predictive performance of breast cancer index (BCI) and clinical treatment score post-5 years (CTS5) in the IDEAL study.

被引：0
作者：
Liefers, Gerrit-Jan
Noordhoek, Iris
Putter, Hein
Wong, Jenna
Siuliukina, Natalia
Zhang, Yi
Kranenbarg, Elma Meershoek-Klein
Duijm-de Carpentier, Marjolijn
Van De Velde, Cornelis J. H.
Schnabel, Catherine A.
Treuner, Kai
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Leiden Univ, Dept Med Stat, Med Ctr, Leiden, Netherlands
[3] Biotheranost Holog Co, San Diego, CA USA
[4] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
545
引用
收藏
页数：1
相关论文
共 50 条
[31]   Assessment of the prognostic and predictive utility of the breast cancer index (BCI): An NCIC CTG MA.14 study. [J].
Sgroi, Dennis ;
Goss, Paul Edward ;
Chapman, Judy-Anne W. ;
Richardson, E. ;
Binns, Shemeica N. ;
Zhang, Yi ;
Schnabel, Catherine A. ;
Erlander, Mark G. ;
Pritchard, Kathleen I. ;
Han, Lei ;
Shepherd, Lois E. ;
Pollak, Michael N. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[32]   The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer [J].
Tajiri, Wakako ;
Ijichi, Hideki ;
Takizawa, Katsumi ;
Koi, Yumiko ;
Masuda, Takanobu ;
Ueo, Hiroki ;
Koga, Chinami ;
Nakamura, Yoshiaki ;
Taguchi, Kenichi ;
Okamoto, Masahiro ;
Tokunaga, Eriko .
BREAST CANCER, 2021, 28 (01) :67-74
[33]   The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer [J].
Wakako Tajiri ;
Hideki Ijichi ;
Katsumi Takizawa ;
Yumiko Koi ;
Takanobu Masuda ;
Hiroki Ueo ;
Chinami Koga ;
Yoshiaki Nakamura ;
Kenichi Taguchi ;
Masahiro Okamoto ;
Eriko Tokunaga .
Breast Cancer, 2021, 28 (1) :67-74
[34]   Clinical impact of differential risk stratification by breast cancer index (BCI) versus recurrence score (RS) in HR plus early-stage breast cancer: A TransATAC study. [J].
Sestak, Ivana ;
Zhang, Yi ;
Schnabel, Catherine A. ;
Schroeder, Brock ;
Ander, Mark Er ;
Goss, Paul E. ;
Cuzick, Jack M. ;
Dowsett, Mitchell ;
Sgroi, Dennis .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[35]   Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5 (vol 14, pg 234, 2019) [J].
Dowsett, Mitch .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06) :656-656
[36]   Clinical validity of CTS5 for estimating risk of late recurrence in unselected, non-trial patients with early ER plus breast cancer. [J].
Richman, Juliet ;
Ring, Alistair E. ;
Dowsett, Mitchell ;
Sestak, Ivana .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[37]   Breast Cancer Index and prediction of benefit from extended endocrine therapy based on treatment compliance: An IDEAL study. [J].
Liefers, Gerrit-Jan ;
Noordhoek, Iris ;
Treuner, Kai ;
Putter, Hein ;
Wong, Jenna ;
Zhang, Yi ;
Kranenbarg, Elma Meershoek-Klein ;
Van de Velde, Cornelis J. H. ;
Schnabel, Catherine A. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[38]   Using the CTS5 Score to Predict Late Recurrence in Male and Female Estrogen Receptor-Positive Breast Cancer Patients: a SEER database analysis of 65,729 cases [J].
Wang, Fenhua ;
Ren, Fang ;
Qian, Jian ;
Xu, Yunxia ;
Wu, Jiayi ;
Zong, Yu ;
Gu, Xidong .
CANCER RESEARCH, 2024, 84 (09)
[39]   Comparative performance of Breast Cancer Index (BCIN+) and CTS5 in hormone receptor-positive (HR plus ) lymph node-positive (N plus ) breast cancer patients with one to three positive nodes (N1). [J].
Sgroi, Dennis ;
Zhang, Yi ;
Schnabel, Catherine A. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[40]   Beyond CTS5 score: A novel nomogram predicting long-term prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer [J].
Zhang, Mingqi ;
Yu, Jing ;
Qin, Liang ;
Wu, Jiayi .
CURRENT PROBLEMS IN CANCER, 2025, 56
12345